🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center Phase II study of fluzoparib combined w...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2023-10-18
Trial ID
NCT06063070
Treatments Being Tested
This first-in-human study aims to establish the maximum tolerated dose of P...
Status
Terminated
Location
Linear Clinical Research Ltd
Start Date
2011-01
Trial ID
NCT01252095
Treatments Being Tested
The purpose of this study is to determine the effectiveness of antiangiogen...
Status
Unknown
Location
Mykolaiv Region Ophthalmogical Hospital
Start Date
2018-03-27
Trial ID
NCT04245072
The purpose of this study is to determine the effectiveness of antiangiogen...
Status
Completed
Location
Mykolaiv Region Ophthalmogical Hospital
Start Date
2018-03-27
Trial ID
NCT03963596
Treatments Being Tested
Sorafenib is a tyrosine kinase inhibitor that is registered for the treatme...
Status
Completed
Location
Radboud University Nijmegen Medical Center
Start Date
2007-07
Trial ID
NCT00602862
Treatments Being Tested
The purpose of this study is to determine the effectiveness of antiangiogen...
Status
Unknown
Location
Mykolaiv Region Ophthalmogical Hospital
Start Date
2018-03-27
Trial ID
NCT04119219
Treatments Being Tested
This research study is being done to compare the efficacy and safety of the...
Status
Not Yet Recruiting
Location
Massachusetts General Hospital
Start Date
2026-08-01
Trial ID
NCT07247097
The purpose of this study is to evaluate the safety and efficacy of ranibiz...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-03-04
Trial ID
NCT01986907
Treatments Being Tested
This phase I single center open labeled study is planned to assess the safe...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2009-11
Trial ID
NCT01020747
Treatments Being Tested
AMD is a disease of the central retina, a zone that enables fine detail act...
Status
Completed
Location
CHU de BESANCON
Start Date
2016-04-28
Trial ID
NCT02557451
Treatments Being Tested